The Clorox's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of The Clorox (CLX) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: The Clorox vs Its Competitors
- TTM: Trailing 12-month revenue of 6,760M vs 376,085M combined for its competitors (1.8% combined share).
- Trending: Latest-quarter revenue run-rate is holding steady (-1.2% annualized vs trailing 12 months), vs decelerating (-3.6%) for its tracked peer group.
- Growth: The Clorox generated 0.1% revenue growth year over year in Q3 2026, vs 6.2% for its competitors combined.
- Profitability: Its 11.4% net margin compares with 15.6% for the peer group.
- Scale: The Clorox ranks #8 of 28 companies by market capitalization in the Personal & Household Products industry, holding 1.4% of industry market cap.
- Peer revenue share: The Clorox accounted for 1.8% of combined revenue among its tracked peer group, down from 1.9% a year earlier.
- Peer differentiation: Revenue per employee of $0.77M compares with $0.56M for the peer group (1.4x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
CLX Sales vs. its Competitors, Q3 2026
The Clorox reported revenue growth of 0.12 % year on year in Q3 2026, below its competitors' combined revenue growth of 6.16 %.
With a net margin of 11.44 %, The Clorox reported lower profitability than its competitors (15.57 %).
The Clorox generated 1.81 % of the combined sales of its peer group, down from 1.92 % a year earlier.
The Clorox vs. its Competitors, Q3 2026
Revenue growth, year on year
Net income growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in The Clorox reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across The Clorox and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| The Clorox Company | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (7) | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (8) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (5) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across The Clorox's competitor groups requires a Commercial License.
For context: the Personal & Household Products industry grew revenue 0.4% year over year, combined, vs 0.1% for The Clorox. The Clorox's share of combined industry revenue moved from 0.88% to 0.88%, a gain of 0.00 percentage points.
The Clorox's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| The Clorox Company | Yes | No | No | No |
| Competitors combined (39) | ||||
| High-Confidence Competitors (7) | ||||
| Similar-Size Competitors (10) | ||||
| Similar Growth & Profitability (8) | 100.00 % (8 of 8) | 87.50 % (7 of 8) | 75.00 % (6 of 8) | 25.00 % (2 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
CLX Stock Performance relative to its Competitors
CLX Stock Performance relative to High-Confidence Competitors
CLX Stock Performance relative to Similar-Size Competitors
CLX Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Tantech Holdings Ltd | 282.9% | Outperformed |
| 2 | Horizon Kinetics Holding Corporation | 282.9% | Outperformed |
| 3 | Tomi Environmental Solutions Inc | 282.9% | Outperformed |
| 4 | Acme United Corp | 282.9% | Outperformed |
| 5 | Sealed Air Corp | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for The Clorox's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
The Clorox's Comment on Competition and Industry Peers
The markets for consumer products are highly competitive. Most of the Company’s products compete with other nationally advertised brands within each category and with “private label” brands. Competition comes from similar and alternative products, some of which are produced and marketed by major multinational or national companies having financial resources greater than those of the Company. Depending on the product, the Company’s products compete on product performance, brand recognition, price, value or other benefits to consumers. A newly introduced consumer product (whether improved or newly developed) usually encounters intense competition requiring substantial expenditures for advertising, sales promotion and trade merchandising support. If a product gains consumer acceptance, it normally requires continued advertising and promotional support and ongoing product improvements to maintain its relative market position.
Publicly Traded Peers of The Clorox Company
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 The Clorox Company |
10,717.26 | 6,760.00 |
 Johnson and Johnson |
668,957.52 | 99,335.00 |
 Procter and Gamble Co |
388,931.30 | 87,922.00 |
 3m Company |
91,110.08 | 25,247.00 |
 Ecolab Inc |
85,470.66 | 17,679.70 |
 Illinois Tool Works Inc |
79,470.32 | 16,646.00 |
| SUBTOTAL | 1,554,968.86 | 459,912.43 |
Sign in to see all competitors of The Clorox Company.
Sources: The Clorox Company's official press releases and company reports; CSIMarket.com's market research; and the company reports and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on The Clorox Company versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
The Clorox's Competitors Named by the Company
Competitive relationships identified from The Clorox reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Tomi Environmental Solutions Inc | Company report | 85% |
| The Honest Company Inc | Company report | 85% |
| Konatel Inc | Company report | 85% |
| Church and Dwight Co Inc | Company report | 85% |
| The Hain Celestial Group Inc | Company report | 85% |
| Grove Collaborative Holdings Inc | Company report | 85% |
| Helen Of Troy Limited | Company report | 85% |
| Kimberly clark Corporation | Company report | 85% |
| Unilever Plc | Company report | 85% |
| Ecolab Inc | Company report | 85% |
| Colgate palmolive Company | Company report | 85% |
| Procter and Gamble Co | Company report | 85% |
| Wd 40 Company | Company report | 85% |
| 3m Company | Company report | 85% |
| Pactiv Evergreen Inc | Company report | 85% |
| Newell Brands Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for The Clorox's named competitors require a Commercial License.
Methodology: relationships are extracted from The Clorox reports (named-competitor disclosures) and corroborating sources. Confidence reflects evidence strength.
The Clorox's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Johnson and Johnson | Oncology 29.93 % |
| Procter and Gamble Co | Fabric & Home Care 35.25 % |
| 3m Company | Safety and Industrial 48.33 % |
| Ecolab Inc | Water Services 51.14 % |
| Illinois Tool Works Inc | Test and Measurement and Electronics 19.33 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for The Clorox Company.
The Clorox's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| The Clorox Company | 10,717 | 768,182 | 87,500 |
| Johnson and Johnson | 668,958 | 705,504 | 114,311 |
| Procter and Gamble Co | 388,931 | 845,404 | 154,750 |
| 3m Company | 91,110 | 417,306 | 58,579 |
| Ecolab Inc | 85,471 | 368,327 | 43,650 |
| Illinois Tool Works Inc | 79,470 | 387,116 | 75,070 |
| PEERS TOTAL | 1,544,252 | 560,032 | 72,983 |
Sign in to see all peers for The Clorox Company.
The Clorox's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Johnson and Johnson | United States 58.90 % |
| Procter and Gamble Co | Non-US 52.05 % |
| 3m Company | United States 46.28 % |
| Mccormick and Company Incorporated | Americas 73.82 % |
| Aptargroup inc | Europe 50.76 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
The Clorox's Position in Industry Market Structure
Market-capitalization share and concentration across all 25 companies in The Clorox's industry classification, broader than the peer set above. Market cap in millions of $.The Clorox ranks #8 of 25 companies by market capitalization in its industry, holding 1.41 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 3,002, indicating a highly concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Procter and Gamble Co | 393,462 | 51.06 % |
| 2 | Ecolab Inc | 85,360 | 11.08 % |
| 3 | Haleon Plc | 80,535 | 10.45 % |
| 4 | Colgate palmolive Company | 76,564 | 9.94 % |
| 5 | Est e Lauder Companies Inc | 1,234 | 5.2% |
| 6 | Kenvue Inc | 1,234 | 5.2% |
| 7 | Church and Dwight Co Inc | 1,234 | 5.2% |
| 8 | The Clorox Company | 10,867 | 1.41 % |
| 9 | E l f Beauty Inc | 1,234 | 5.2% |
| 10 | Yatsen Holding Limited | 1,234 | 5.2% |
Market cap and industry share for the rest of The Clorox's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-10-30.
The Clorox's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 3 | Haleon Plc | 80,535 | -3.31 % |
| 4 | Colgate palmolive Company | 76,564 | 26.09 % |
| 5 | Est e Lauder Companies Inc | 39,094 | 10.07 % |
| 6 | Kenvue Inc | 37,297 | 35.53 % |
| 7 | Church and Dwight Co Inc | 1,234 | 12.3% |
| 8 | The Clorox Company | 10,867 | -19.60 % |
| 9 | E l f Beauty Inc | 1,234 | 12.3% |
| 10 | Yatsen Holding Limited | 1,234 | 12.3% |
| 11 | Interparfums Inc | 1,234 | 12.3% |
| 12 | Coty Inc | 1,234 | 12.3% |
| 13 | Stepan Company | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of The Clorox's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-10-30. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
The Clorox's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Personal & Household Products industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (54 companies). See the full Personal & Household Products industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 43.85 % | 23.78 % (avg) | +20.1 pp |
| Operating Margin | 26.39 % | industry median | +23.5 pp |
| EBITDA Margin | 19.64 % | 4.30 % (avg) | +15.3 pp |
| Capital Intensity (Capex / Revenue) | 2.90 % | 2.44 % (avg) | +0.5 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
The Clorox's Valuation vs Competitive Position
Valuation multiples vs the Personal & Household Products industry average (54 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Personal & Household Products industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | 18.4x | 26.5x | -8.0x |
| EV / EBITDA | 12.3x | 16.8x | -4.5x |
| P/B | 46.3x | 4.4x | +41.9x |
| Return on Equity | 257.96 % | industry aggregate | 232.73 % |
| Return on Invested Capital | 42.10 % | -0.78 % (avg) | 42.88 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
The Clorox's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | 3.38 % | -1.78 % | 22.68 % | -5.90 % | -0.21 % | 3.47 % | -1.98 % | -5.68 % |
| Operating Margin | 27.58 % | 28.03 % | 30.70 % | 17.27 % | 20.00 % | 14.66 % | 27.05 % | 26.16 % |
| Return on Invested Capital | 38.30 % | 38.40 % | 37.30 % | 23.74 % | 27.47 % | 23.02 % | 39.38 % | 41.29 % |
| P/E | 25.9x | 23.8x | 21.3x | 86.1x | 41.3x | 211.6x | 44.7x | 17.8x |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
The Clorox's Strategic Group Map
Every company in The Clorox's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. The Clorox is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
The Clorox's trailing-12-month revenue growth of -3.7% and operating margin of 26.4% compares with an average of 4.4% growth and 17.1% margin across its 8 closest peers by combined growth, margin and ROIC -- The Clorox sits below that peer average on growth and above it on margin.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
The Clorox's BCG Growth-Share Matrix
Relative market share (vs The Clorox's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
The Clorox falls in the Dog quadrant: relative market share of 0.03x vs its largest competitor, in an industry growing revenue 1.2% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution. A caveat worth reading alongside this chart: Procter and Gamble Co alone holds 51% of this industry's market cap. In an industry this dominated by one leader, the framework will place nearly every OTHER company in "Dog" or "Question Mark" purely because relative share is measured against that leader, regardless of how strong those other companies actually are on their own fundamentals. Check the Profitability, Valuation and Financial Strength sections above before treating this quadrant label as a verdict.
The Clorox's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Low | Industry HHI of 3,002 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | High (capital intensive) | Capital intensity (capex / revenue) of 2.90 % vs industry average 2.44 % (see Profitability & Cost Structure above) |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments. Supplier power and buyer power are not assessed here -- see The Clorox's dedicated Suppliers and Customers pages for concentration data; threat of substitutes has no systematic data source in this system and is not estimated.
The Clorox's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
The Clorox falls in the Medium attractiveness / Medium strength cell: Selective.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
The Clorox's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Operating margin 23.5 points above the industry median.
- Return on equity 232.7 points above the industry aggregate.
Weaknesses
- Underperforming the U.S.A. 500 over the trailing 12 months.
- Low relative market share vs the industry leader (0.03x).
Opportunities
- Trades at a lower P/E than the industry average (18.4x vs 26.5x) despite a higher return on invested capital -- a possible re-rating opportunity.
Threats
- Industry dominated by Procter and Gamble Co, holding 51.06 % of industry market cap.
- Tracked peer group's revenue run-rate is broadly decelerating (-3.6% annualized).
- High capital intensity requires continuous reinvestment just to keep pace with the industry.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
The Clorox's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| The Clorox Company | 0.18 | 0.82 | 9.85 |
| Johnson and Johnson | 0.36 | 1.04 | 0.60 |
| Procter and Gamble Co | 0.26 | 0.71 | 0.71 |
| 3m Company | - | 1.47 | 3.62 |
| Ecolab Inc | 0.29 | 1.26 | 1.72 |
| Illinois Tool Works Inc | 0.15 | 1.20 | 2.98 |
Sign in to see all peers for The Clorox Company.
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
The Clorox's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| The Clorox Company | Q1 2026 | +0.1 % | +0.0 % |
| Johnson and Johnson | Q3 2026 | +5.9 % | -95.9 % |
| Procter and Gamble Co | Q3 2026 | +4.0 % | -1.0 % |
| 3m Company | Q3 2026 | +1.0 % | +63.3 % |
| Ecolab Inc | Q3 2026 | +16.4 % | -6.5 % |
| Illinois Tool Works Inc | Q3 2026 | +4.4 % | +4.1 % |
| PEERS TOTAL | +2.4 % | -5.6 % |
Sign in to see all peers for The Clorox Company.
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
The Clorox's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| The Clorox Company | Q1 2026 | +2.6 % | - |
| Johnson and Johnson | Q3 2026 | +10.9 % | +17.7 % |
| Procter and Gamble Co | Q3 2026 | +7.3 % | +13.8 % |
| 3m Company | Q3 2026 | +0.2 % | +17.4 % |
| Ecolab Inc | Q3 2026 | +14.2 % | +19.8 % |
| Illinois Tool Works Inc | Q3 2026 | -12.8 % | -12.8 % |
Sign in to see all peers for The Clorox Company.
The Clorox's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| The Clorox Company | 13.34% | 19.55% | 257.96% |
| Johnson and Johnson | 8.06% | 10.53% | 19.55% |
| Procter and Gamble Co | 12.54% | 17.47% | 29.71% |
| 3m Company | 9.60% | 13.24% | 93.07% |
| Ecolab Inc | 7.57% | 7.61% | 20.76% |
| Illinois Tool Works Inc | 19.74% | 22.80% | 103.35% |
Sign in to see all peers for The Clorox Company.
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
The Clorox's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| The Clorox Company | 14.31 | 1.59 |
| Johnson and Johnson | 41.33 | 6.73 |
| Procter and Gamble Co | 24.44 | 4.42 |
| 3m Company | 25.98 | 3.61 |
| Ecolab Inc | 41.33 | 4.83 |
| Illinois Tool Works Inc | 36.18 | 4.77 |
| PEERS AVERAGE | 25.99 | 3.38 |
Sign in to see all peers for The Clorox Company.
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.